Randomised trial of simulect versus placebo for control of acute rejection in renal allograft recipients.
Bingyi
S
S
Department of Urology, Professor and Director, Hospital of PLA, Beijing, China.
Yeyong
Q
Q
Ming
C
C
Chunbai
M
M
Wenqiang
Z
Z
D000328:Adult; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007262:Infusions, Intravenous; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011184:Postoperative Period; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D013997:Time Factors; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D010919:Placebos; D011993:Recombinant Fusion Proteins